Also known as: Ostarine
MK-2866, also known as Ostarine, is a selective androgen receptor modulator (SARM) categorized under anabolic and myostatin peptides. It was initially developed to treat muscle wasting and osteoporosis, aiming to provide the benefits of anabolic steroids without the associated side effects. MK-2866 is recognized for its potential to enhance muscle mass and strength, making it a focus of research in the field of performance enhancement.
MK-2866 operates by selectively binding to androgen receptors in muscle and bone tissues. This selective action promotes anabolic activity, leading to increased protein synthesis and muscle growth while minimizing unwanted effects on other tissues.
The binding of MK-2866 to androgen receptors triggers a cascade of biological processes that enhance muscle regeneration and growth. By mimicking the effects of testosterone, it stimulates muscle hypertrophy and improves overall physical performance without significantly affecting other organs.
MK-2866 serves as a notable SARM in the realm of anabolic and myostatin peptides, primarily aimed at combating muscle wasting. Its selective action on androgen receptors positions it as a valuable research compound with potential applications in various muscle-related conditions.
Last updated: Feb 25, 2026